Farzan Abdolahi, MD

Dr. Farzan Abdolahi, M.D. investigates the development and clinical application of cutting edge technologies for early diagnosis and treatment of diseases directly affecting the eye and disorders with ophthalmic manifestations, such as diabetic retinopathy, age-related macular degeneration, glaucoma, and vascular contributions to cognitive impairment and dementia. The current focus of Dr. Abdolahi’s research is on preventing blindness and visual impairment through the development of imaging biomarkers of retinal vasculature with early clinical diagnostic value, and with the goal of making them widely available for use in the clinic.

• Retinal perfusion is linked to cognition and brain MRI biomarkers in Black Americans Alzheimers Dement. 2024 Feb; 20(2):858-868. . View in PubMed
• A retinal imaging system for combined measurement of optic nerve head vascular pulsation and stimulated vasodilation in humans Sci Rep. 2023 10 10; 13(1):17149. . View in PubMed
• Past, present and future role of retinal imaging in neurodegenerative disease Prog Retin Eye Res. 2021 07; 83:100938. . View in PubMed
• Optical Coherence Tomography Angiography-Derived Flux As a Measure of Physiological Changes in Retinal Capillary Blood Flow Transl Vis Sci Technol. 2021 08 02; 10(9):5. . View in PubMed
• A gene-disease association study of IL18 in thyroid cancer: genotype and haplotype analyses Endocrine. 2015 Dec; 50(3):698-707. . View in PubMed
• Effect of intradermal injection of heparinase III on skin wound healing in diabetic rats G Ital Dermatol Venereol. 2014 Aug; 149(4):427-33. . View in PubMed

• Shahidi, Mahnaz
• Angell, Trevor
• Humayun, Mark